CP
BCPC

Castleview Partners’s Balchem Corp BCPC Stock Holding History

Castleview Partners’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,284
Closed -$61 – 1044
2021
Q4 		$61 Buy
+10,284
New +$1.65M ﹤0.01% 863

Other funds holding BCPC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Castleview Partners's BCPC Position: Q1 2022 in Review

Castleview Partners sold out of Balchem Corp (BCPC) in Q1 2022, closing a stake of 10,284 shares — an estimated $61 sold.

Castleview Partners first reported a position in BCPC in Q4 2021 and held it in 1 quarter. The position peaked at $61 in Q4 2021. 299 funds tracked by Wall St. Rank hold BCPC as of Q1 2022.

  • Castleview Partners reported no remaining Balchem Corp position as of Q1 2022 after selling out during the quarter.
  • Castleview Partners sold 10,284 Balchem Corp shares in Q1 2022, an estimated $61.
  • Castleview Partners first reported a position in Balchem Corp in Q4 2021 and held it in 1 quarter.
  • Castleview Partners's Balchem Corp position peaked at $61 in Q4 2021.
  • 299 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2022.

Based on Castleview Partners's 13F filing for Q1 2022, filed 16 May 2022.